Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study

BACKGROUND: Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its use is limited by side effects. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Boesby, Lene, Elung-Jensen, Thomas, Klausen, Tobias Wirenfeldt, Strandgaard, Svend, Kamper, Anne-Lise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208556/
https://www.ncbi.nlm.nih.gov/pubmed/22073219
http://dx.doi.org/10.1371/journal.pone.0026904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208556/
https://www.ncbi.nlm.nih.gov/pubmed/22073219
http://dx.doi.org/10.1371/journal.pone.0026904

Ejemplares similares